Tuesday, August 26, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Downgrades Maxeon Solar Technologies Ltd from Neutral to Sell

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_Cash
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, UBS analyst William Grippin made a bold move by downgrading Maxeon Solar Technologies Ltd. (NASDAQ: MAXN) from Neutral to Sell, while also slashing the price target from $7 to $3. This unexpected downgrade indicates a pessimistic view on the company’s performance moving forward.

Maxeon Solar Technologies, headquartered in Singapore, is known for its innovative designs and manufacturing of solar panels under the Maxeon and SunPower brands. With a global presence in over 100 countries, the company holds a significant market share in the solar industry. Maxeon Solar Technologies boasts a wide range of products, including the Maxeon line of solar cells and panels, as well as the Performance line of shingled solar cells and panels.

UBS’s recent downgrade of Maxeon Solar Technologies hints at a cautious approach to the company’s future prospects. With access to approximately 1,000 patents, the company’s innovative capabilities are undeniable. However, the downgrade serves as a warning sign for investors to proceed with caution when considering Maxeon Solar Technologies as a potential investment option.

MAXN Stock Sees Decline in Performance on March 8, 2024

On March 8, 2024, MAXN stock saw a decline in its performance, with the share price dropping by $0.02 or 0.50% since the market last closed. The stock closed at $4.00, and in pre-market trading, it further dropped by $0.21. MAXN is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock is facing some downward pressure and may be struggling to gain momentum. Investors and analysts will be closely watching MAXN’s performance in the coming days to see if the stock can rebound from its recent losses.

MAXN Stock Performance: Mixed Results in Financial Report for Past Year and Third Quarter

MAXN stock had a mixed performance on March 8, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, MAXN’s total revenue for the past year was $1.06 billion, showing a 35.34% increase compared to the previous year. However, the total revenue for the third quarter was $227.63 million, indicating a 34.66% decrease compared to the previous quarter.

In terms of net income, MAXN reported a net loss of $267.42 million for the past year, which represents a 5.07% decrease compared to the previous year. The net loss for the third quarter was $108.26 million, showing a significant decrease of 7074.09% compared to the previous quarter.

Earnings per share (EPS) for MAXN were also impacted by these results. The EPS for the past year was -$6.54, showing a 3.82% increase compared to the previous year. However, the EPS for the third quarter was -$2.21, indicating a drastic decrease of 6524.85% compared to the previous quarter.

Overall, MAXN’s stock performance on March 8, 2024, reflected the company’s mixed financial results. Investors will be closely monitoring MAXN’s future financial performance to assess the company’s growth prospects and potential for recovery.

Tags: MAXN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Retailers Stock Bull Market

Analyst Perspectives on BJs Wholesale Club A Mixed Bag of Opinions

Finance_Assets (3)

CNBC Experts Share Final Trades for March 8 2024

Technology Cloud computing

Analysts Bullish on Samsara with Increased Price Target

Recommended

Jefferies Analyst Upgrades Corbus Pharmaceuticals to Buy Raises Price Target

1 year ago
Block Stock

Block Stock: Downgrade Clashes With S&P 500 Optimism

3 weeks ago
Logistics Stock Market Today (2)

Targets Shipment Disruptions Amidst Red Sea Crisis

2 years ago
FLO stock news

Investor Sentiment and Options Activity for First Solar as of March 6 2024

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE Adobe ADSK ALB AMD AMZN Apple AVGO BA C COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM IBM INTC Intel JPM LLY META Micron MSFT NFLX NIO NVDA NVO Opendoor PARA PLTR Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

MSA Safety: A Stock Caught Between Strong Fundamentals and Lofty Valuations

Legend Biotech’s Surging Revenue Fuels Analyst Confidence Despite Ongoing Losses

Prestige Consumer Healthcare Faces Strategic Crossroads After Disappointing Quarter

Major Investor Trims Stake in QuantumScape

Mixed Signals Emerge from Piper Sandler’s Strong Quarterly Performance

Brazilian Steelmaker Cia Siderurgica Nacional Shows Dramatic Loss Reduction

Trending

Lam Research Stock
Stocks

Lam Research Shares Surge as Analysts Revise Targets Upward

by Dieter Jaworski
August 26, 2025
0

Lam Research has once again demonstrated its role as a cornerstone of the semiconductor equipment sector. The...

Repligen Stock

Repligen Stock: Navigating Divergent Signals in Biotech Markets

August 26, 2025
Cleveland-Cliffs Stock

Major Institutions Bet Big on Cleveland-Cliffs Stock

August 26, 2025
MSA Safety Stock

MSA Safety: A Stock Caught Between Strong Fundamentals and Lofty Valuations

August 26, 2025
Legend Biotech Corp Stock

Legend Biotech’s Surging Revenue Fuels Analyst Confidence Despite Ongoing Losses

August 26, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Lam Research Shares Surge as Analysts Revise Targets Upward August 26, 2025
  • Repligen Stock: Navigating Divergent Signals in Biotech Markets August 26, 2025
  • Major Institutions Bet Big on Cleveland-Cliffs Stock August 26, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com